Alejandro J. Cagnoni
Consejo Nacional De Investigaciones Científicas Y Técnicas, B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Reprogramming T cell fate through antibody-mediated galectin-1 blockade.
Journal: Methods in cell biology
Published: July 13, 2026
Design of galectin-1-conjugated nanoparticles as potential immunomodulatory agents.
Journal: RSC medicinal chemistry
Published: June 15, 2025
Different roles of the heterodimer architecture of galectin-4 in selective recognition of oligosaccharides and lipopolysaccharides having ABH antigens.
Journal: The Journal of biological chemistry
Published: March 15, 2024
Exploring galectin interactions with human milk oligosaccharides and blood group antigens identifies BGA6 as a functional galectin-4 ligand.
Journal: The Journal of biological chemistry
Published: March 15, 2024
Selective modifications of lactose and N-acetyllactosamine with sulfate and aromatic bulky groups unveil unique structural insights in galectin-1-ligand recognition.
Journal: Bioorganic & medicinal chemistry
Published: July 15, 2023
Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 12, 2023
Targeting galectin-driven regulatory circuits in cancer and fibrosis.
Journal: Nature reviews. Drug discovery
Published: December 20, 2022
Untangling Galectin-Mediated Circuits that Control Hypoxia-Driven Angiogenesis.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 23, 2022
Last Updated: 09/26/2026